Abecma Or Bust: 2seventy Sells Final Research Program To Novo

hemophilia
2Seventy sold rights to a hemophilia A program to Novo Nordisk • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from Deals

More from Business